Date Name Title Filing Type Shares Traded Price Total Held
Jan 05, 2005
VP, Regulatory Development
VP, Regulatory Development Form 4 Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) 5,147 -- --
Jan 05, 2005
VP, Regulatory Development
VP, Regulatory Development Form 4 Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) 6,350 -- --
Jan 05, 2005
VP, Regulatory Development
VP, Regulatory Development Form 4 Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) 19,853 -- --
Jan 05, 2005
VP, Regulatory Development
VP, Regulatory Development Form 4 Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) 20,000 -- --
Jan 05, 2005
VP, Regulatory Development
VP, Regulatory Development Form 4 Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) 13,650 -- --
Nov 30, 2012
VP Regulat Dev & Med Safety
VP Regulat Dev & Med Safety Form 4 Open market or private sale of non-derivative or derivative security 200 $184.29 200
Nov 30, 2012
VP Regulat Dev & Med Safety
VP Regulat Dev & Med Safety Form 4 Open market or private sale of non-derivative or derivative security 800 $183.58 400
Feb 06, 2014
VP Reg Dev & Med Safety
VP Reg Dev & Med Safety Form 5 Other acquisition or disposition -- -- 1,200
Feb 06, 2014
VP Reg Dev & Med Safety
VP Reg Dev & Med Safety Form 5 Other acquisition or disposition -- -- 1,200
Sep 20, 2013
VP Reg Dev & Med Safety
VP Reg Dev & Med Safety Form 4 Other acquisition or disposition -- -- 1,200

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.